Regulation
FDA Untitled Letter Cites Evolus Over a Jeuveau Instagram Reel
FDA's drug-promotion office told Evolus on September 28, 2026 that a Jeuveau Instagram reel was false or misleading. Here is what the five-page letter says.
Dana Whitlock · October 8, 2026